Effect of Skimmed Milk on the Absorption and Metabolism of 5-Fluorouracil (5-FU) in Animals

被引:0
作者
Ahmad, Maqsood [2 ]
Ghumman, Shazia Akram [1 ]
Alamgeer [1 ]
Sharif, Tanveer [2 ]
Sher, Muhammad [1 ]
Abbas, Tahir [3 ]
机构
[1] Univ Sargodha, Dept Pharm, Sargodha, Pakistan
[2] GC Univ Faisalabad, Coll Pharm, Faisalabad, Pakistan
[3] Univ Punjab, Dept Zool, Lahore, Pakistan
来源
IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH | 2012年 / 11卷 / 01期
关键词
5-FU; 5-Fdurd; Plasma concentration; Hematological parameter; Skimmed milk; Route related toxicity; DIHYDROPYRIMIDINE DEHYDROGENASE; ESCHERICHIA-COLI; PLASMA; FLUOROURACIL; PHARMACOKINETICS; CARCINOMA;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Several modalities of drug administration have been investigated to improve bioavailability and to reduce 5-FU related toxicity. The aim of present study was to evaluate the effect of skimmed milk on the absorption and metabolism of 5-FU in rabbits, mice and dogs. It was further aimed to determine its route related toxicity in rabbits. Plasma concentration of both 5-FU and its metabolite 5-Fluoro-2-deoxyuridine (5-Fdurd) was determined using HPLC. The absorption of 5-FU co-administered with skimmed milk was significantly higher as compared to its co-administration with water in rabbits and mice (p < 0.001), whereas no significant difference was observed in dogs. The plasma concentration of 5-Fdurd a major metabolite of 5-FU was significantly higher in water group when compared with skimmed milk group in rabbits and mice (p < 0.05), whereas no significant difference was observed in dogs. Route related toxicity was also determined in rabbits. Various hematological parameters were studied at 4th and 7th day after oral and intravenous administration of 5-FU. WBCs count was significantly decreased in intravenous group as compared to control and oral groups (p < 0.001). It was concluded that co-administration of skimmed milk with 5-FU increases its absorption and reduces its metabolism. Skimmed milk also reduces 5-FU related toxicity in rabbits.
引用
收藏
页码:69 / 75
页数:7
相关论文
共 27 条
  • [1] Ahmad M, 2008, PHARM ONLINE, V3, P100
  • [2] Baydar M, 2005, J NATL MED ASSOC, V97, P1161
  • [3] Simultaneous HPLC determination of 5-fluorouracil and its metabolites in plasma of cancer patients
    Casale, F
    Canaparo, R
    Muntoni, E
    Serpe, L
    Zara, GP
    Pepa, CD
    Berno, E
    Costa, M
    Eandi, M
    [J]. BIOMEDICAL CHROMATOGRAPHY, 2002, 16 (07) : 446 - 452
  • [4] FLUOROURACIL THERAPY IN PATIENTS WITH CARCINOMA OF LARGE BOWEL - PHARMACOKINETIC COMPARISON OF VARIOUS RATES AND ROUTES OF ADMINISTRATION
    CHRISTOPHIDIS, N
    VAJDA, FJE
    LUCAS, I
    DRUMMER, O
    MOON, WJ
    LOUIS, WJ
    [J]. CLINICAL PHARMACOKINETICS, 1978, 3 (04) : 330 - 336
  • [5] Exposure of oral mucosa to bioactive milk factors reduces severity of chemotherapy-induced mucositis in the hamster
    Clarke, J
    Butler, R
    Howarth, G
    Read, L
    Regester, G
    [J]. ORAL ONCOLOGY, 2002, 38 (05): : 478 - 485
  • [6] COHEN JL, 1974, CANCER CHEMOTH REP 1, V58, P723
  • [7] CRESSY NL, 1965, AM J MED SCI, V249, P78
  • [8] The oral fluorinated pyrimidines
    de Bono, JS
    Twelves, CJ
    [J]. INVESTIGATIONAL NEW DRUGS, 2001, 19 (01) : 41 - 59
  • [9] Diasio RB, 1998, ONCOLOGY-NY, V12, P23
  • [10] A RANDOMIZED TRIAL OF FLUOROURACIL AND FOLINIC ACID IN PATIENTS WITH METASTATIC COLORECTAL-CARCINOMA
    ERLICHMAN, C
    FINE, S
    WONG, A
    ELHAKIM, T
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (03) : 469 - 475